524202.BO Stock Analysis
52
Neutral
Based on Eyestock quantitative analysis, 524202.BO`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Market cap $B
0.007
Dividend yield
—
Shares outstanding
12.59 B
Lactose India Ltd. engages in manufacturing of pharmaceutical and other pharmaceutical products. The company is headquartered in Mumbai, Maharashtra. The firm principally engaged in the manufacturing of lactose monohydrate. The Company’s products are available in various segments, such as liquid dosage form, solid dosage forms, excipients and active pharmaceutical ingredients. The company manufactures disaccharide lactulose. The company manufactures dry granulated, film and lacquer coated tablets. The firm is also engaged in producing pharma color coatings in a room facility, which has an installed capacity of approximately 180 metric tons/annum. The firm offers prebiotic-galacto-oligosaccharides (GOS), which is used in various applications, such as dairy products, beverages, bakery products, infant nutrition, clinical nutrition, products for children or adolescents, and geriatric nutrition. The firm's plant is located at Taluka Savli, Vadodara, Gujarat.